Both in Pharmaceuticals
Valion Bio vs Decoy Therapeutics
Over the past year VBIO returned −77.1% and DCOY returned −57.3%; their daily moves had a correlation of -0.03.
VBIO −77.1% DCOY −57.3%Growth of $1, one year, split-adjusted
| Metric | VBIO | DCOY |
|---|---|---|
| Price | $0.5171 | $1.14 |
| Market cap | $1.1M | $746.9K |
| Today | −2.60% | +2.70% |
| 1 month | −78.3% | −26.5% |
| 6 months | — | −81.0% |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1042.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$5.3M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 123.4% |
| Short % of float | 9.0% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).